PAKISTAN
Macter International Limited has announced that it has obtained the requisite licenses for its Pre-Filled Syringe (PFS) and Pre-Filled Pen (PFP) manufacturing facilities within its biotechnology division, marking a major advancement in the company’s production capabilities.
With these new licenses, Macter now possesses the capability to manufacture all three key injectable biotechnology dosage forms — Vials, Pre-Filled Syringes, and Pre-Filled Pens.
Terming it a significant milestone, the company said this achievement will enable it to introduce advanced biotechnological products designed to offer greater therapeutic benefits and enhanced convenience for patients.
The expansion underscores Macter’s commitment to strengthening its biotech manufacturing footprint in Pakistan, improving patient access to quality and innovative treatments, and aligning with global standards in healthcare technology. – ER News Desk
READ MORE STORIES ON HEALTHCARE
